Leadership and Governance
Board of Directors
Our leadership team bring many years of expertise in life sciences, finance and venture, as well as the dynamism and strategic awareness to apply it.
Ian joined the Board of Malin as Chairman in July 2018.
Ian served as CFO of Smurfit Kappa Group, a FTSE 100 company, having spent 26 years in total with Smurfit Kappa. Most recently, he was CEO of Ardagh Group, during which time Ardagh listed on the NYSE.
Presently Ian serves as a non-executive director of MidCap Financial, a specialist lender managed by Apollo Capital Management.
A graduate of University College Dublin, Ian also holds an MBA from the Michael Smurfit Graduate School of Business and is a Fellow of the Chartered Institute of Management Accountants.
Rudy joined the Board of Malin as Lead Independent Non-Executive Director in July 2018.
Rudy is CEO of Polyganics B.V., a Dutch medical technology company, and currently serves as Chairman on the Boards of NeutriLeads, Medichem S.A, VitalNext and the Supervisory Board of Organ Assist. He has formerly served as CEO of Synthon, President of Cardinal Health, President and executive board member of Royal Numico and held the position of worldwide VP/General Manager of the Business Development Biosciences Division of Becton Dickinson.
Jean-Michel joined the Board of Malin as Independent Non-Executive Director in July 2018.
Jean-Michel previously spent 10 years at GE Healthcare as the Chief Marketing Officer and VP, Global Marketing. More recently, he served as VP, North American Oncology with Eli Lilly, as well as Managing Director Northern Europe.
Jean-Michel holds an MBA from the Rotterdam School of Management (Erasmus University). He received his PhD with honours in Nuclear Chemistry and Neurobiology from the University of Paris and conducted post-doctoral research in Neuropharmacology at the National Institutes of Health in the US. Additionally, he holds a Pharm D with honours in Pharmacology from the University of Paris.
Liam joined the Board of Malin as Independent Non-Executive Director in March 2015.
Liam is also a non-executive director of Horizon Pharma plc and was president of the Institute of Directors in Ireland from 2013 to 2015. He served with Elan Corporation plc from 1993 until 2014 in various roles including executive vice president and as an executive director.
A graduate of University College Dublin, Liam is also a Fellow of Chartered Accountants Ireland and a Chartered Director.
Darragh joined Malin as CFO in March 2014.
Darragh served as an Executive Director until July 2018 and was appointed Chief Business and Financial Officer in November 2018.
Prior to joining Malin, Darragh held a number of senior finance positions in Elan Corporation plc and worked with PwC in Dublin, the US and Canada, including serving in PwC's Global Technical Accounting Group.
Darragh is a Fellow of Chartered Accountants Ireland.
Sean joined Malin in July 2016.
Sean served as a senior adviser at Evercore Partners from 2011 to 2018. Prior to this role, Sean was the Head of Corporate M&A and Business Development at Abbott.
In a career that spans over 30 years, Sean's experience in the life sciences sector is both operational and transactional, having run Abbott’s vascular business and played a leading role in a number of strategic investments during his tenure.